• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
US currency next to a ruler pen and calculator
Special Reports

Top 10 pharma R&D budgets of 2025

All of the companies on this year's list also made last year's ranking, but most of them made substantial cuts to their R&D spending.
Darren Incorvaia Mar 30, 2026 3:00am
Sleep disorder insomnia

Lilly pays $6.3B upfront for sleep disorder-focused Centessa

Mar 31, 2026 8:53am
Fierce Biotech43png

Scaling Radioligand Therapy: Expanding the Impact of Theranostics

Brought to you by Curium
positive negative up down good bad mixed

AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal

Mar 31, 2026 5:35am
Coral reef sea underwater

Merck dives into data showing PCSK9 pill easily outswims rivals

Mar 30, 2026 11:45am
closed shuttered shut down closed
Favicon Fierce Pharma

Iterum initiates wind-down after failure to offload antibiotic

Mar 31, 2026 2:06pm
More News

After FDA refusal, IO Biotech surrenders to bankruptcy

Mar 31, 2026 10:17am

Ambrosia scores $100M series B to advance next-gen oral GLP-1

Mar 31, 2026 10:02am

Fierce Biotech Layoff Tracker 2026: Lipella, IO, Takeda & more

Mar 31, 2026 10:00am

BMS links up with Faro to use AI to improve trial protocols

Mar 31, 2026 9:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings